Viking Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
/PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...
New York United States San Francisco Prnewswire Viking Therapeutics Inc Ligand Pharmaceuticals Incorporated Company Positioned To Announce Data
Source: prnewswire.com